Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 1
1950 2
1952 2
1953 4
1954 1
1955 2
1956 1
1957 1
1958 1
1960 1
1961 1
1962 3
1963 1
1964 1
1966 1
1969 1
1970 3
1971 4
1972 2
1973 1
1974 4
1975 5
1976 2
1977 5
1978 2
1979 7
1980 5
1981 11
1982 11
1983 9
1984 8
1985 7
1986 6
1987 10
1988 11
1989 6
1990 7
1991 14
1992 11
1993 7
1994 19
1995 13
1996 14
1997 10
1998 16
1999 12
2000 16
2001 9
2002 20
2003 19
2004 11
2005 21
2006 24
2007 16
2008 13
2009 19
2010 27
2011 27
2012 24
2013 22
2014 41
2015 32
2016 39
2017 36
2018 32
2019 40
2020 43
2021 41
2022 46
2023 41
2024 32
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

884 results

Results by year

Filters applied: . Clear all
Page 1
Ovarian cancer.
Jayson GC, Kohn EC, Kitchener HC, Ledermann JA. Jayson GC, et al. Lancet. 2014 Oct 11;384(9951):1376-88. doi: 10.1016/S0140-6736(13)62146-7. Epub 2014 Apr 21. Lancet. 2014. PMID: 24767708 Review.
ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†.
Colombo N, Sessa C, du Bois A, Ledermann J, McCluggage WG, McNeish I, Morice P, Pignata S, Ray-Coquard I, Vergote I, Baert T, Belaroussi I, Dashora A, Olbrecht S, Planchamp F, Querleu D; ESMO-ESGO Ovarian Cancer Consensus Conference Working Group. Colombo N, et al. Ann Oncol. 2019 May 1;30(5):672-705. doi: 10.1093/annonc/mdz062. Ann Oncol. 2019. PMID: 31046081 Free article.
Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
González-Martín A, Harter P, Leary A, Lorusso D, Miller RE, Pothuri B, Ray-Coquard I, Tan DSP, Bellet E, Oaknin A, Ledermann JA; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. González-Martín A, et al. Ann Oncol. 2023 Oct;34(10):833-848. doi: 10.1016/j.annonc.2023.07.011. Epub 2023 Aug 17. Ann Oncol. 2023. PMID: 37597580 Free article. No abstract available.
Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer.
Ledermann J, Harter P, Gourley C, Friedlander M, Vergote I, Rustin G, Scott C, Meier W, Shapira-Frommer R, Safra T, Matei D, Macpherson E, Watkins C, Carmichael J, Matulonis U. Ledermann J, et al. N Engl J Med. 2012 Apr 12;366(15):1382-92. doi: 10.1056/NEJMoa1105535. Epub 2012 Mar 27. N Engl J Med. 2012. PMID: 22452356 Free article. Clinical Trial.
Rushi Ledermann. 1916-2009.
Kaplinsky C. Kaplinsky C. J Anal Psychol. 2010 Feb;55(1):155-7. doi: 10.1111/j.1468-5922.2009.01831_2.x. J Anal Psychol. 2010. PMID: 20433510 No abstract available.
Mucinous Ovarian Carcinoma.
Hackshaw A, Gershenson D, Ledermann J. Hackshaw A, et al. N Engl J Med. 2019 Jul 4;381(1):e3. doi: 10.1056/NEJMc1905728. N Engl J Med. 2019. PMID: 31269388 No abstract available.
Frontline Maintenance Treatment for Ovarian Cancer.
Elyashiv O, Wong YNS, Ledermann JA. Elyashiv O, et al. Curr Oncol Rep. 2021 Jun 14;23(8):97. doi: 10.1007/s11912-021-01088-w. Curr Oncol Rep. 2021. PMID: 34125335 Free PMC article. Review.
Targeted Therapies for Ovarian Cancer.
Grunewald T, Ledermann JA. Grunewald T, et al. Best Pract Res Clin Obstet Gynaecol. 2017 May;41:139-152. doi: 10.1016/j.bpobgyn.2016.12.001. Epub 2016 Dec 8. Best Pract Res Clin Obstet Gynaecol. 2017. PMID: 28111228 Review.
884 results